“Cholesterol” is the most quoted and least understood health number. The standard panel gives four: total cholesterol, HDL, LDL, triglycerides. Yet patients with a perfectly normal LDL have heart attacks, and patients with a frankly elevated LDL never will. The reading of the lipid panel has changed over the past twenty years: we now know that what matters is not the quantity of cholesterol carried, but the number and size of the particles carrying it. This article reads the advanced panel; its twin treats cholesterol as Phlegm in the Blood in the TCM reading.
LDL-c alone is not enough: the case of sdLDL
LDL-c measures the mass of cholesterol inside LDL particles, not their number or their nature. Two people at the same LDL-c can carry very different risks: the one whose cholesterol travels in a few large buoyant particles is at lower risk than the one carrying it in a crowd of small dense particles, the sdLDL (small dense LDL). These slip more easily through the artery wall, oxidise faster there, and linger longer in circulation.
sdLDL are not a fate: they reflect the metabolic context. Insulin resistance, excess fructose, fatty overload of the liver manufacture this profile. That is why LDL-c alone misclassifies: it can be normal with plenty of sdLDL, or elevated with only large buoyant particles.
apoB: counting particles, not cholesterol
Every atherogenic particle (LDL, VLDL, IDL, Lp(a)) carries exactly one molecule of apolipoprotein B. Measuring apoB therefore amounts to counting the particles capable of entering the artery wall, regardless of their cholesterol load. It is the most direct marker of risk, and the major European cardiology societies now recommend it as the preferred target, ahead of LDL-c.
A high apoB with a normal LDL-c means many underfilled particles (the sdLDL profile). A low apoB with a high LDL-c means few well-filled particles (the less dangerous profile). The test costs a few pounds and is easy to prescribe; it answers the question LDL-c leaves open.
Lp(a): the genetic factor almost nothing changes
Lipoprotein(a) is a modified LDL, fixed by inheritance: its level is more than 90 % genetically determined and moves neither with diet nor with exercise. An elevated Lp(a) (beyond 50 mg/dL or 125 nmol/L) multiplies cardiovascular risk independently of everything else on the panel. About one person in five carries this profile unknowingly.
The honest point: diet does not lower Lp(a). What it can do is reduce overall risk that much more aggressively (blood pressure, inflammation, other particles) to offset a factor it cannot touch. Statins do not lower it either; new molecules (antisense siRNA) are under evaluation.
Triglycerides: the fructose marker
Triglycerides measure the fats circulating in the blood between meals. Their rise is the earliest and most readable signal on the panel: it almost always reflects an excess of fast sugar and fructose (soft drinks, juices, alcohol, refined products) that the liver turns into fat once it overflows. The triglyceride/HDL ratio (in mmol/L) serves as a proxy for insulin resistance: above 2, resistance is probable.
Triglycerides climbing while LDL stays put tell the start of the metabolic continuum, the one preceding prediabetes and fatty liver. It is the marker most sensitive to diet: two weeks of frankly cutting sugar and alcohol are enough to watch it fall.
Dietary levers by marker
Each marker has a dominant lever; there is not one cholesterol diet but several precise gestures.
To lower apoB and sdLDL: cut refined carbohydrates and liquid fructose (soft drinks, juices, syrups), which manufacture small dense particles; raise soluble fibre (oats, pulses, psyllium) which captures bile acids; favour monounsaturated fats (olive, nuts, avocado) which remodel the profile.
To lower triglycerides: remove liquid fructose and alcohol, reduce the overall glycaemic load, raise EPA/DHA omega-3s (oily fish, ground flax) which cut hepatic VLDL production. This is the fastest-responding marker.
To offset high Lp(a): strategy shifts to the other levers (blood pressure, inflammation, smoking, apoB), since the marker itself does not move. Vitamin C and niacin have marginal effects and do not replace overall risk management.
To support HDL: it does not rise on a pill, it rises with regular aerobic exercise, smoking reduction and overall plate quality. HDL is a reflection of the terrain more than a direct target.
Frequently asked questions about the lipid panel
Should apoB be measured at every panel?
No. apoB adds most when LDL-c is discordant with the clinical picture (diabetes, insulin resistance, family history) or when the precision of the target matters. First-line, LDL-c, triglycerides and the TG/HDL ratio suffice for most profiles.
My Lp(a) is high, what can I do?
Not much on the marker itself, which is genetic. But a high Lp(a) makes managing overall risk more important: controlled blood pressure, low apoB, reduced inflammation, no smoking. It is a reason to be more rigorous on the other levers, not to panic about this one.
Does dietary cholesterol raise blood cholesterol?
Far less than was believed. The liver adjusts its production inversely to intake: eggs, long forbidden, raise LDL-c only marginally in most people. The real engine of LDL is the mix of fast sugars + saturated fats + caloric overload, not the cholesterol on the plate.
Is soluble fibre worth a statin?
No, but it adds usefully. Ten grams of soluble fibre a day (oats, psyllium, pulses) lowers LDL-c by 5 to 10 %, comparable to a half-dose of statin without side effects. At moderate risk, it may suffice; at high risk, it complements treatment.
Count the particles, not the cholesterol
The lipid panel has grown sharper: LDL-c remains useful but insufficient, and three markers (apoB, sdLDL, Lp(a), triglycerides) draw the real landscape of risk. Diet does not act on all of them equally: it lowers triglycerides in two weeks, remodels particles in a few months, and does not touch genetic Lp(a). Knowing which number answers which lever is reading the panel for what it is: a map of the metabolic terrain, not a verdict.
In the Yin Shi app, the food sheets give each product’s soluble fibre and omega-3 content: oats and psyllium tick the boxes of LDL-c to remodel, ground flaxseed those of triglycerides to bring down.
Further reading: cholesterol as Phlegm in the Blood in TCM, the anti-inflammatory diet, the glycaemic index and the sweet flavour, the Mediterranean diet read in Chinese dietetics, and inflammatory obesity.
To go further
Yin Shi ecosystem resources directly related to this article.
Is your plate protecting your lipids?
The MEDAS score measures the Mediterranean model — the benchmark for lipid balance.
Take the test →Reading the lipid panel beyond LDL
The lesson details apoB, sdLDL and Lp(a), which the standard panel does not show.
Take the lesson →